Technology
Agencies and drugmakers are struggling to generate consistent standards and regulatory criteria for evaluating autologous cell therapies.
Labs Ask Medicare Contractor to Refine Coverage Policy for 'Comprehensive' NGS Cancer Testing
Premium
National Government Services' proposal to broaden coverage of large sequencing panels for solid tumor patients is positive but may need clarification to ensure appropriate patient care.
They hope the website will be an unbiased source for genetic risk information, testing, and financial support services and spur cascade testing in families.
LXRepair, Gustave Roussy Ink Research Partnership in Personalized Radiotherapy
The French biotech and cancer center have launched a joint lab to advance LXRepair's DNA-based functional assays to predict patients' responses to radiation.
Physician Bias May Contribute to Lower Genetic Testing Rates Among Black Women, Study Suggests
Researchers explored how oncologists' beliefs about the barriers Black breast cancer patients face in accessing genetic counseling and testing might influence testing referrals.